[Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis]
- PMID: 16496762
[Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis]
Abstract
Statistics for the last 6 years show a trend to growing number of new cases with tuberculosis of the lungs with drug-resistant pathogen. In recurrent tuberculosis multiple drug resistance (MDR) was three times higher than in new cases. Treatment efficacy depended on MDR and patients' compliance. The results of the basic treatment course were unstable: many patients had exacerbation within 3-4 years after therapy, many patients died, especially those with M. tuberculosis resistant to many drugs.
Similar articles
-
[Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].Arch Inst Pasteur Madagascar. 2002;68(1-2):44-7. Arch Inst Pasteur Madagascar. 2002. PMID: 12643091 French.
-
Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.Int J Tuberc Lung Dis. 2002 Dec;6(12):1098-101. Int J Tuberc Lung Dis. 2002. PMID: 12546118
-
[Drug-resistant pulmonary tuberculosis at the penitentiaries].Probl Tuberk Bolezn Legk. 2008;(12):60-3. Probl Tuberk Bolezn Legk. 2008. PMID: 19227326 Russian.
-
Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment.Br Med Bull. 2005 Jun 14;73-74:17-24. doi: 10.1093/bmb/ldh047. Print 2005. Br Med Bull. 2005. PMID: 15956357 Review.
-
Treatment of multidrug-resistant tuberculosis: evidence and controversies.Int J Tuberc Lung Dis. 2006 Aug;10(8):829-37. Int J Tuberc Lung Dis. 2006. PMID: 16898365 Review.